CD95L pro-drug: a novel Swiss Army Knife in cancer therapy?

Kassahn, D; Nachbur, U; Brunner, T (2007). CD95L pro-drug: a novel Swiss Army Knife in cancer therapy? Cell death and differentiation, 14(3), pp. 393-4. Basingstoke: Nature Publishing Group 10.1038/sj.cdd.4402069

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

Brunner, Thomas

ISSN:

1350-9047

ISBN:

17301839

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:48

Last Modified:

06 Dec 2013 13:42

Publisher DOI:

10.1038/sj.cdd.4402069

PubMed ID:

17301839

Web of Science ID:

000244275400001

URI:

https://boris.unibe.ch/id/eprint/19918 (FactScience: 2995)

Actions (login required)

Edit item Edit item
Provide Feedback